Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells

References

• Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283: 845–848
   PubMed Web of Science ®Google Scholar
• Durig J, Schmucker U, Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia 2001; 15: 752–756
   PubMed Web of Science ®Google Scholar
• Sanz-Rodriguez F, Hidalgo A, Teixido J. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 2001; 97: 346–351
   PubMed Web of Science ®Google Scholar
• Hideshima T, Chauhan D, Hayashi T, et al. The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma. Mol Cancer Ther 2002; 1: 539–544
   PubMed Web of Science ®Google Scholar
• Moller C, Stromberg T, Juremalm M, Nilsson K, Nilsson G. Expression and function of chemokine receptors in human multiple myeloma. Leukemia 2003; 17: 203–210
   PubMed Web of Science ®Google Scholar
• Gazitt Y, Akay C. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4. Stem Cell 2004; 22: 65–73
   PubMed Web of Science ®Google Scholar
• Alsayed Y, Ngo H, Runnels J, et al. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 2007; 109: 2708–2717
   PubMed Web of Science ®Google Scholar
• Zannettino A C, Farrugia A N, Kortesidis A, et al. Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Cancer Res 2005; 65: 1700–1709
   PubMed Web of Science ®Google Scholar
• Van de Broek I, Leleu X, Schots R, et al. Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival. Haematologica 2006; 91: 200–206
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Pellegrino A, Dammacco F. [Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects]. Ann Ital Med Int 2000; 15: 7–19
   PubMedGoogle Scholar
• Guleng B, Tateishi K, Ohta M, et al. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 2005; 65: 5864–5871
   PubMed Web of Science ®Google Scholar
• Liesveld J L, Bechelli J, Rosell K, et al. Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells. Leuk Res 2007; 31: 1553–1563
   PubMed Web of Science ®Google Scholar
• De Clercq E. Antiviral drug discovery and development: where chemistry meets with biomedicine. Antiviral Res 2005; 67: 56–75
   PubMed Web of Science ®Google Scholar
• Odemis V, Moepps B, Gierschik P, Engele J. Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression. Implications for brain inflammation. J Biol Chem 2002; 277: 39801–39808
   PubMed Web of Science ®Google Scholar
• Ohira S, Sasaki M, Harada K, et al. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma. Am J Pathol 2006; 168: 1155–1168
   PubMed Web of Science ®Google Scholar
• Lopez Ponte A, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007; 25: 1737–1745
   PubMed Web of Science ®Google Scholar
• Buckley C D, Amft N, Bradfield P F, et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 2000; 165: 3423–3429
   PubMed Web of Science ®Google Scholar
• Hosokawa Y, Hosokawa I, Ozaki K, et al. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease. Clin Exp Immunol 2005; 141: 467–474
   PubMed Web of Science ®Google Scholar
• Gupta S K, Lysko P G, Pillarisetti K, Ohlstein E, Stadel J M. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 1998; 273: 4282–4287
   PubMed Web of Science ®Google Scholar
• Katayama A, Ogino T, Bandoh N, Nonaka S, Harabuchi Y. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. Clin Cancer Res 2005; 11: 2937–2946
   PubMed Web of Science ®Google Scholar
• Salcedo R, Wasserman K, Young H A, et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 1999; 154: 1125–1135
   PubMed Web of Science ®Google Scholar
• Bachelder R E, Wendt M A, Mercurio A M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002; 62: 7203–7206
   PubMed Web of Science ®Google Scholar
• Wang J, Harada A, Matsushita S, et al. IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication. J Leukoc Biol 1998; 64: 642–649
   PubMed Web of Science ®Google Scholar
• Nagase H, Miyamasu M, Yamaguchi M, et al. Glucocorticoids preferentially upregulate functional CXCR4 expression in eosinophils. J Allergy Clin Immunol 2000; 106: 1132–1139
   PubMed Web of Science ®Google Scholar
• Caulfield J, Fernandez M, Snetkov V, Lee T, Hawrylowicz C. CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells. Immunology 2002; 105: 155–162
   PubMed Web of Science ®Google Scholar
• Felszeghy K, Banisadr G, Rostene W, Nyakas C, Haour F. Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 2004; 11: 404–413
   PubMed Web of Science ®Google Scholar
• Schioppa T, Uranchimeg B, Saccani A, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 2003; 198: 1391–1402
   PubMed Web of Science ®Google Scholar
• Ceradini D J, Gurtner G C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005; 15: 57–63
   PubMed Web of Science ®Google Scholar
• Zagzag D, Lukyanov Y, Lan L, et al. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 2006; 86: 1221–1232
   PubMed Web of Science ®Google Scholar
• Schutyser E, Su Y, Yu Y, et al. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw 2007; 18: 59–70
   PubMed Web of Science ®Google Scholar
• Zhang Y, Foudi A, Geay J F, et al. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells 2004; 22: 1015–1029
   PubMed Web of Science ®Google Scholar
• Signoret N, Oldridge J, Pelchen-Matthews A, et al. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol 1997; 139: 651–664
   PubMed Web of Science ®Google Scholar
• Bruhl H, Cohen C D, Linder S, Kretzler M, Schlondorff D, Mack M. Post-translational and cell type-specific regulation of CXCR4 expression by cytokines. Eur J Immunol 2003; 33: 3028–3037
   PubMed Web of Science ®Google Scholar
• Tarasova N I, Stauber R H, Michejda C J. Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4. J Biol Chem 1998; 273: 15883–15886
   PubMed Web of Science ®Google Scholar
• Asosingh K, De Raeve H, de Ridder M, et al. Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression. Haematologica 2005; 90: 810–817
   PubMed Web of Science ®Google Scholar
• Price P, Keane N, Gray L, Lee S, Gorry P R, French M A. CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy. Viral Immunol 2006; 19: 734–740
   PubMed Web of Science ®Google Scholar
• Semenza G L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551–578
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole D R, Tian Y M, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468–472
   PubMed Web of Science ®Google Scholar
• Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464–468
   PubMed Web of Science ®Google Scholar
• Schutyser E, Su Y, Yu Y, et al. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw 2007; 18: 11–22
   Google Scholar
• Skommer J, Wlodkowic D, Pelkonen J. Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4. Exp Hematol 2007; 35: 84–95
   PubMed Web of Science ®Google Scholar
• Crazzolara R, Bernhard D. CXCR4 chemokine receptors, histone deacetylase inhibitors and acute lymphoblastic leukemia. Leuk Lymphoma 2005; 46: 1545–1551
   PubMed Web of Science ®Google Scholar
• Skommer J, Wlodkowic D, Pelkonen J. CXCR4 expression during tumour cell death. Leuk Res 2007; 31: 1155–1156
   PubMed Web of Science ®Google Scholar